Synexus Polska Sp. z o.o.

At Synexus Polska Sp. z o.o. in Poznan, clinical research in nervous system diseases focuses on chronic peripheral neuropathic pain, including pain linked to postherpetic neuralgia and peripheral nerve injury. The studies are designed to assess whether new treatment options can reduce pain and improve daily comfort for affected adults.

• Evaluating a new therapy for chronic neuropathic pain
• Measuring improvement in pain intensity and symptom control

This area reflects a practical effort to find better ways to manage persistent nerve pain when standard approaches are not enough.

Research in musculoskeletal diseases at this site includes rheumatoid arthritis and post-menopausal osteoporosis. The trials are aimed at understanding how well potential treatments can ease joint symptoms, slow disease-related damage, and support bone health in people living with long-term inflammatory or bone-loss conditions.

• Testing treatment effectiveness in rheumatoid arthritis
• Assessing bone-strengthening approaches for osteoporosis

These studies help clarify whether newer options may offer better control of disease activity and longer-term protection for patients.

The nutritional and metabolic diseases portfolio includes studies in Non Alcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH), and fibrosis. Research here is centered on evaluating therapies that may improve liver health, reduce scarring, and lower the risk of serious disease progression in people with metabolic liver disease.

• Investigating liver disease improvement in NASH and MASH
• Studying whether treatment can limit fibrosis progression

This work is especially important for identifying treatments that address both inflammation and long-term liver damage.

Clinical trials in skin and connective tissue diseases are focused on moderate to severe atopic dermatitis. The main goal is to determine whether investigational treatments can better relieve itching, redness, and skin inflammation while improving overall disease control in adults with persistent symptoms.

• Evaluating therapies for atopic dermatitis symptom relief
• Measuring improvement in skin severity and daily burden

This research supports the search for more effective options for people whose skin disease remains difficult to manage.

The site also conducts research in immune system diseases, with a strong focus on rheumatoid arthritis as an inflammatory condition driven by immune dysfunction. These studies are intended to compare treatment options, assess safety and tolerability, and understand whether newer therapies can provide sustained benefit over time.

• Comparing therapies for inflammatory joint disease
• Assessing long-term safety and effectiveness in rheumatoid arthritis

With an active clinical research team in Oddział w Poznaniu, the site contributes to better understanding of how immune-targeted treatments may improve patient outcomes.